Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Morphological remodeling in atrial fibrillation].

Andreas Goette1, Uwe Lendeckel

  • 1Klinik für Kardiologie, Angiologie und Pneumologie, Otto-von-Guericke-Universitätsklinik, Magdeburg. andreas.goette@medizin.uni-magdeburg.de

Herz
|June 2, 2006
PubMed
Summary

Atrial fibrillation (AF) causes electrical and structural remodeling, including fibrosis. Gene therapy offers a novel approach to convert fibroblasts into cardiomyocytes, potentially restoring electrical conduction in fibrotic atrial tissue.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: Exploratory analysis of the EAST-AFNET 4 Biomolecule Study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Effectiveness and Safety of Early Rhythm Control in Patients With Atrial Fibrillation and Chronic Kidney Disease.

Journal of the American College of Cardiology·2026
Same author

Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AF.

European journal of internal medicine·2026
Same author

Within the eye of atrial fibrillation.

International journal of cardiology·2026
Same author

The POTCAST trial: relatively small adjustments of potassium levels have a big clinical benefit in ICD patients.

European heart journal. Acute cardiovascular care·2025

Area of Science:

  • Cardiology
  • Molecular Biology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) involves complex electrophysiological and structural remodeling of atrial tissue.
  • Key changes include L-type calcium channel downregulation and protease-mediated alterations, contributing to arrhythmia perpetuation.
  • Cardiac diseases activate the atrial angiotensin II system, promoting pro-arrhythmogenic fibrosis.

Purpose of the Study:

  • To review the pathophysiology of atrial fibrillation, focusing on electrical and structural remodeling.
  • To explore novel therapeutic strategies for AF, particularly those addressing atrial fibrosis.
  • To evaluate the potential of viral gene transfer for fibroblast-to-cardiomyocyte conversion.

Main Methods:

  • Review of current literature on atrial fibrillation pathophysiology.

Related Experiment Videos

  • Analysis of mechanisms underlying electrical and structural remodeling in AF.
  • Examination of experimental data on gene therapy for cardiac tissue regeneration.

    • Main Results:

    • AF induces significant electrophysiological changes (electrical remodeling) and structural alterations (structural remodeling).
    • Proteases like calpain and calcineurin mediate calcium-dependent tissue changes.
    • Atrial fibrosis, driven by the angiotensin II system, is a key pro-arrhythmogenic factor.
    • Viral gene transfer shows promise in converting fibroblasts to cardiomyocytes.

    Conclusions:

    • Understanding AF pathophysiology is crucial for developing effective treatments.
    • Targeting fibrosis and exploring regenerative approaches like gene therapy are promising avenues.
    • Fibroblast-to-cardiomyocyte conversion via gene therapy may restore electrical conduction in fibrotic atrial tissue.